Skip to main content

Table 2 Baseline participant characteristics

From: The optimal timing of FDG-PET/CT in non-small cell lung cancer diagnosis and staging in an Australian centre

Demographic

% (n) or Median(IQR)

Age (years)

71 (63–79)

Gender

 Male

55.6% (64)

 Female

44.4% (51)

Final NSCLC clinical stage

 I

43.5% (50)

 II

19.1% (22)

 IIIa

14.8% (17)

 IIIb

10.4% (12)

 IV

12.2% (14)

NSCLC histology

 Adenocarcinoma

65.2% (75)

 Squamous cell carcinoma

28.7% (33)

 Non-small cell other

6.1% (7)

  1. NSCLC Non-small cell lung cancer
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us